Upadacitinib Effects on Entheseal Domain in Psoriatic Arthritis Patients - a Pooled "post-hoc" Analysis from Two Phase III Studies (Select PsA 1 and 2)

被引：0
|
作者：
Cantini, Fabrizio [1 ]
Marchesoni, Antonio [2 ]
Marando, Francesca [3 ]
Gualberti, Giuliana [3 ]
Novelli, Lucia [3 ]
Curradi, Giacomo [3 ]
McDearmon--Blondell, Erin [4 ]
Gao, Tianming [5 ]
Salvarani, Carlo [6 ]
机构：
[1] Hosp Prato, Dept Rheumatol, Azienda USL Toscana Ctr, Prato, Italy
[2] ASST Gaetano Pini CTO, Dipartimento Reumatol, Milan, Italy
[3] AbbVie, Rome, Italy
[4] AbbVie Inc, Elmhurst, IL USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Azienda USL IRCCS Reggio Emilia, Unita Operat Reumatol, Reggio Emilia, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1340
引用
收藏
页码：2789 / 2791
页数：3
相关论文
共 50 条
  • [1] Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials
    Cantini, Fabrizio
    Marchesoni, Antonio
    Novelli, Lucia
    Gualberti, Giuliana
    Marando, Francesca
    McDearmon-Blondell, Erin L.
    Gao, Tianming
    McGonagle, Dennis
    Salvarani, Carlo
    RHEUMATOLOGY, 2024,
  • [2] Comparison of Composite Indices for Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib: A Post-Hoc Analysis from SELECT-PsA 1
    Smolen, Josef
    Lubrano, Ennio
    Kishimoto, Mitsumasa
    Balanescu, Andra R.
    Strand, Vibeke
    Gao, Tianming
    Vranich, Nancy
    Lippe, Ralph
    Tillett, William
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3790 - 3792
  • [3] COMPARISON OF COMPOSITE INDICES FOR DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: A POST-HOC ANALYSIS FROM SELECT-PSA 1
    Smolen, J. S.
    Lubrano, E.
    Kishimoto, M.
    Balanescu, A.
    Strand, V.
    Gao, T.
    Vranich, N.
    Lippe, R.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 824 - 824
  • [4] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, P. J.
    Kavanaugh, A.
    Gladman, D. D.
    Fitzgerald, O.
    Soriano, E.
    Nash, P.
    Feng, D.
    Lertratanakul, A.
    Douglas, K.
    Lippe, R.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1294 - 1295
  • [5] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
  • [6] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    Fitzgerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinva
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laura
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 45 - 45
  • [7] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    FitzGerald, Oliver
    Soriano, Enrique R.
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1181 - 1191
  • [9] Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
    Philip Mease
    Arthur Kavanaugh
    Dafna Gladman
    Oliver FitzGerald
    Enrique R. Soriano
    Peter Nash
    Dai Feng
    Apinya Lertratanakul
    Kevin Douglas
    Ralph Lippe
    Laure Gossec
    Rheumatology and Therapy, 2022, 9 : 1181 - 1191
  • [10] Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
    Conaghan, Philip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Marchbank, Katie
    Edwards, Christopher J.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
12345